Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
about
Chronic immune activation and inflammation as the cause of malignancyRisk of non-Hodgkin lymphoma in association with germline variation in complement genesVirus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected CellsStructural Basis for Recognition of the Pore-Forming Toxin Intermedilysin by Human Complement Receptor CD59Nonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitorsCharacterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancerInhibiting complement regulators in cancer immunotherapy with bispecific mAbs.Self-nonself discrimination by the complement system.Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.Cancer and complement.Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis.Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.Antibody-based immunotherapy in high-risk neuroblastoma.The role of complement in tumor growthPlasma proteome changes associated with refractory cytopenia with multilineage dysplasiaQuantitative proteomic analysis of meningiomas for the identification of surrogate protein markers.Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells.Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.Ascitic complement system in ovarian cancerSecretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells.B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.Engineered measles virus as a novel oncolytic therapy against prostate cancer.Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells.Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.Rapid degradation of the complement regulator, CD59, by a novel inhibitorCD46 plasticity and its inflammatory bias in multiple sclerosis.Complement in cancer and cancer immunotherapy.Mechanisms of action of CD20 antibodies.Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.Complement inhibition in cancer therapy.Protein engineering to target complement evasion in cancer.Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.Complement factor H in host defense and immune evasion.
P2860
Q24648532-6F2BB286-5104-4377-9A52-3D372E0092AEQ24648778-F92A5B16-F891-4EF2-BB6A-9BF1F99A93E9Q27488397-B07BF363-7A12-43ED-8B7F-10BE7A78835DQ27678091-02447C66-121F-417D-BEB3-5794242A3421Q27693185-35C89656-E5FE-40CD-8994-793F96603DADQ28235980-05A94362-541C-4AFF-86C4-FF00035344F3Q33228198-5D8933C7-8A67-4234-9F8A-E7C7EF9B1F79Q33433754-05E7C002-DBE0-44DE-A2DB-32A3059C6ADEQ33550600-EF4CCD30-F6F6-42F6-A450-87C8E03BE581Q33567710-4475BCB9-2276-45C2-83FC-334CB3C26DACQ33787962-4C4CDB5F-7AFF-4281-ACAB-E65545E5AA7FQ34256060-9279A789-5B92-4DD4-8948-CB0D0EBA7019Q34725758-26B4BCAE-D09F-4162-AAAF-B8114E20439AQ35231345-DF546338-AB06-41AC-AB9D-CF026E115F0CQ35338994-A205A8AA-2662-47EC-BCD6-9B67FB980D00Q35440783-10A88AE5-82D8-4142-80A5-BF0CE557AA30Q35506520-E1D287F5-FADD-495A-95D2-FB95F589FFDCQ35927368-20A8BFF2-3CDE-4BF5-A7BE-39A766E36234Q36616364-195B6C01-BE90-4697-8C27-CA66C9889DDBQ36646213-FA0AF9D2-CF8C-4405-BC77-DADEA569A011Q36897408-65C7F833-E5DB-4A8E-AF16-A5FC9A523C52Q37067601-2C856F1B-9A3E-4267-BC22-CFE3F7C17ABEQ37189823-F6CB8C12-E29F-4F8D-97FD-1D49D43299DEQ37189831-C7986CAA-B257-43FF-AFC5-F762847492DFQ37332702-E4C07D91-8BC4-41A6-B674-F979AC5C3BBFQ37377923-4FC54A5C-D9EE-41B5-9FF3-57764384BD9CQ37681488-3EE597E8-AE9D-46A7-837C-E9EFCCB1EB86Q37727650-4E67129E-7DBD-41F7-A979-1B74E4ED0824Q37832444-B495CEFB-0ED8-471B-8840-3BF6F27E4897Q37940918-E7BF30D7-7D14-4A13-BC3B-B219FEA4DE6FQ38066195-54148235-8D2B-41AE-85DE-CD840427AD57Q38068141-94E317EA-6D66-4838-95EA-4A94095E52C8Q38109340-5F192451-48D7-4AA2-BB82-96C73C11A37BQ38163242-6996BC45-1D92-4D3E-A863-77DADDD901C2Q38168921-7D80E962-D47D-4B07-A20A-46D5E83A52ABQ38730371-5EF16914-2D1E-4CD0-BA9F-7929233F56BFQ38895520-9D392AE2-CC84-4561-AE56-B3A6F798A0D8Q38940506-161E5E58-1C84-4AE8-B77D-EEA39D789083Q39001370-6622C2BB-E01B-4149-9F92-C9A3B52CC02CQ39036058-E2EEA520-460B-44AB-942F-09394100DB3A
P2860
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@ast
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@en
type
label
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@ast
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@en
prefLabel
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@ast
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@en
P1433
P1476
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
@en
P304
P356
10.1016/S0167-5699(99)01537-6
P577
1999-12-01T00:00:00Z